| Aggregatibacter actinomycetemcomitans–induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis MF Konig, L Abusleme, J Reinholdt, RJ Palmer, RP Teles, K Sampson, ... Science Translational Medicine 8 (369), 369ra176-369ra176, 2016 | 640 | 2016 |
| Targeting a neoantigen derived from a common TP53 mutation EHC Hsiue, KM Wright, J Douglass, MS Hwang, BJ Mog, AH Pearlman, ... Science 371 (6533), eabc8697, 2021 | 291 | 2021 |
| A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination MF Konig, F Andrade Frontiers in immunology 7, 461, 2016 | 263 | 2016 |
| Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists MF Konig, M Powell, V Staedtke, RY Bai, DL Thomas, N Fischer, S Huq, ... The Journal of Clinical Investigation 130 (7), 2020 | 161* | 2020 |
| SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 151 | 2022 |
| Bispecific antibodies targeting mutant RAS neoantigens J Douglass, EHC Hsiue, BJ Mog, MS Hwang, SR DiNapoli, AH Pearlman, ... Science Immunology 6 (57), eabd5515, 2021 | 141 | 2021 |
| Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology MF Konig, AS Paracha, M Moni, CO Bingham, F Andrade Annals of the Rheumatic Diseases 74 (11), 2054-2061, 2015 | 141 | 2015 |
| Targeting public neoantigens for cancer immunotherapy AH Pearlman, MS Hwang, MF Konig, EHC Hsiue, J Douglass, ... Nature Cancer 2 (8), 865-867, 2021 | 133 | 2021 |
| Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 MF Konig, AHJ Kim, MH Scheetz, ER Graef, JW Liew, J Simard, ... Annals of the Rheumatic Diseases, 2020 | 97 | 2020 |
| The microbiome in autoimmune rheumatic disease MF Konig Best Practice & Research Clinical Rheumatology 34 (1), 101473, 2020 | 91 | 2020 |
| Targeting loss of heterozygosity for cancer-specific immunotherapy MS Hwang, BJ Mog, J Douglass, AH Pearlman, EHC Hsiue, S Paul, ... Proceedings of the National Academy of Sciences 118 (12), e2022410118, 2021 | 72 | 2021 |
| Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19 SE Sattui, JW Liew, ER Graef, A Coler-Reilly, F Berenbaum, ... Expert Review of Clinical Immunology 16 (7), 659-666, 2020 | 69 | 2020 |
| Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis MF Konig, JT Giles, PA Nigrovic, F Andrade Annals of the rheumatic diseases 75 (11), 2022-2028, 2016 | 68 | 2016 |
| Higher Hydroxychloroquine Blood Levels Are Associated with Reduced Thrombosis Risk in Systemic Lupus Erythematosus M Petri, MF Konig, J Li, DW Goldman Arthritis & Rheumatology, 2021 | 59* | 2021 |
| Rheumatoid arthritis-associated autoimmunity due to Aggregatibacter actinomycetemcomitans and its resolution with antibiotic therapy A Mukherjee, V Jantsch, R Khan, W Hartung, R Fischer, J Jantsch, ... Frontiers in Immunology 9, 2352, 2018 | 54 | 2018 |
| Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection A Koenecke, M Powell, R Xiong, Z Shen, N Fischer, S Huq, ... Elife 10, e61700, 2021 | 52* | 2021 |
| Cancer therapy with antibodies S Paul, MF Konig, DM Pardoll, C Bettegowda, N Papadopoulos, ... Nature Reviews Cancer 24 (6), 399-426, 2024 | 51 | 2024 |
| TCR β chain–directed bispecific antibodies for the treatment of T cell cancers S Paul, AH Pearlman, J Douglass, BJ Mog, EHC Hsiue, MS Hwang, ... Science Translational Medicine 13 (584), eabd3595, 2021 | 51 | 2021 |
| Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases JS Hausmann, K Kennedy, JF Simard, JW Liew, JA Sparks, TT Moni, ... The Lancet Rheumatology 3 (10), e707-e714, 2021 | 49 | 2021 |
| Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis E Darrah, JT Giles, RL Davis, P Naik, H Wang, MF Konig, LC Cappelli, ... Frontiers in Immunology 9, 2018 | 49 | 2018 |
Felipe AndradeJohns Hopkins UniversityVerifisert e-postadresse på jhmi.edu